O
Organon
Sustainability Report and Carbon Intensity Rankings
Is Organon doing their part?
Their DitchCarbon score is 57
Organon has a DitchCarbon Score of 57 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is room for improvement in reducing emissions. A higher score would signify greater success in achieving lower carbon intensity and better environmental performance.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Organon is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Organon, located in the United States, operates in a region with a low carbon intensity rating. This suggests that the company’s sustainability efforts are supported by the country’s relatively low reliance on carbon-intensive energy sources.
Unlock 30+ emissions data points on Organon
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Organon
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
15.71%
...this company is doing 15.71% better in emissions than the industry average.
Organon, founded in Oss, the Netherlands, is a renowned player in the pharmaceutical industry, particularly known for its development of birth control pills. The company, which began its journey in the Dutch city, has experienced growth and undergone acquisitions, first by Schering Plough and subsequently by Merck, now operating as MSD in the Netherlands. With its current headquarters in Jersey City, Organon continues to make significant contributions to healthcare and pharmaceuticals.
emission intelligence's platform recommendations for Organon
Organon should set clear, science-based targets for reducing Scope 3 emissions, maintain transparency in reporting their progress, and promote environmental sustainability throughout their supply chain, which could potentially lower their emissions by 35%.
Good news, Organon has set science-based climate targets
Organon has established Science Based Targets initiative (SBTi) commitments to significantly reduce its greenhouse gas emissions from company operations, which include direct emissions and indirect emissions from purchased energy. These targets align with the ambitious goal of limiting global temperature rise to 1.5°C above pre-industrial levels.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.